Achyut Healthcare Ltd
Incorporated in 1996, Achyut Healthcare Ltd is a pharmaceutical trading company dealing in API, Pharmaceutical products, medical devices, etc.[1]
- Market Cap ₹ 85.5 Cr.
- Current Price ₹ 3.63
- High / Low ₹ 6.25 / 2.82
- Stock P/E 155
- Book Value ₹ 1.33
- Dividend Yield 0.00 %
- ROCE 2.26 %
- ROE 1.77 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
Cons
- Stock is trading at 2.62 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 2.06% over last 3 years.
- Company has high debtors of 160 days.
- Promoter holding has decreased over last 3 years: -20.1%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
0.67 | 0.33 | 0.27 | 4.05 | 2.70 | 6.14 | 3.05 | |
0.66 | 0.32 | 0.26 | 4.08 | 2.97 | 6.12 | 3.25 | |
Operating Profit | 0.01 | 0.01 | 0.01 | -0.03 | -0.27 | 0.02 | -0.20 |
OPM % | 1.49% | 3.03% | 3.70% | -0.74% | -10.00% | 0.33% | -6.56% |
0.00 | 0.01 | 0.00 | 0.14 | 0.59 | 0.73 | 0.92 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 |
Profit before tax | 0.01 | 0.02 | 0.01 | 0.10 | 0.31 | 0.74 | 0.70 |
Tax % | 300.00% | 0.00% | 0.00% | 60.00% | 25.81% | 22.97% | 22.86% |
-0.01 | 0.01 | 0.01 | 0.04 | 0.23 | 0.57 | 0.55 | |
EPS in Rs | -0.02 | 0.02 | 0.02 | 0.00 | 0.01 | 0.02 | 0.02 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 56% |
3 Years: | -9% |
TTM: | -50% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 123% |
3 Years: | 140% |
TTM: | -4% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 52% |
1 Year: | -3% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 2% |
3 Years: | 2% |
Last Year: | 2% |
Balance Sheet
Figures in Rs. Crores
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
Equity Capital | 0.25 | 0.25 | 0.25 | 6.74 | 9.35 | 16.83 | 23.56 |
Reserves | -0.05 | -0.04 | 0.00 | 2.34 | 5.18 | 13.93 | 7.74 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
0.04 | 0.06 | 0.25 | 0.86 | 0.81 | 0.19 | 1.29 | |
Total Liabilities | 0.24 | 0.27 | 0.50 | 9.94 | 15.34 | 30.95 | 32.59 |
0.00 | 0.00 | 0.00 | 0.03 | 0.05 | 0.06 | 0.03 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 3.49 | 9.16 | 18.19 |
Investments | 0.00 | 0.00 | 0.00 | 1.70 | 1.30 | 0.00 | 0.00 |
0.24 | 0.27 | 0.50 | 8.21 | 10.50 | 21.73 | 14.37 | |
Total Assets | 0.24 | 0.27 | 0.50 | 9.94 | 15.34 | 30.95 | 32.59 |
Cash Flows
Figures in Rs. Crores
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
-0.03 | -0.02 | 0.01 | -6.96 | -0.43 | -0.36 | -4.06 | |
0.00 | 0.00 | 0.00 | -1.60 | -4.81 | -15.23 | 4.69 | |
0.00 | 0.00 | 0.00 | 8.79 | 5.21 | 15.72 | 0.00 | |
Net Cash Flow | -0.03 | -0.02 | 0.01 | 0.24 | -0.03 | 0.14 | 0.62 |
Ratios
Figures in Rs. Crores
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
Debtor Days | 54.48 | 188.03 | 378.52 | 18.02 | 36.50 | 24.37 | 160.36 |
Inventory Days | 0.00 | 0.00 | 158.70 | 14.29 | 59.59 | 3.96 | 24.16 |
Days Payable | 380.87 | 41.78 | 55.87 | 9.24 | 143.71 | ||
Cash Conversion Cycle | 54.48 | 188.03 | 156.34 | -9.46 | 40.22 | 19.09 | 40.81 |
Working Capital Days | 76.27 | 210.15 | 216.30 | 603.83 | 1,257.22 | 1,242.43 | 1,169.20 |
ROCE % | 9.76% | 4.35% | 2.14% | 2.63% | 3.27% | 2.26% |
Documents
Announcements
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 20 Jun
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 19 Jun
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 9 Jun
-
Appointment of Company Secretary and Compliance Officer
5 Jun - Appointment of Kaushalkumar Dave as Company Secretary & Compliance Officer on 05/06/2025.
-
Board Meeting Outcome for OUTCOME OF Board MEETING
5 Jun - Appointed Kaushalkumar Dave as Company Secretary and Compliance Officer effective June 5, 2025.
Business Overview:[1]
Company is in the manufacturing of
pharmaceutical formulations in the
forms of Tablets, Capsules, Oral liquid
and Injectables.